Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
27.14
+0.11 (0.41%)
Apr 30, 2026, 3:00 PM CST
SHA:603351 Market Cap
SHA:603351 has a market cap or net worth of 3.68 billion as of April 30, 2026. Its market cap has increased by 5.40% in one year.
Market Cap
3.68B
Enterprise Value
3.84B
Revenue
1.34B
Ranking
n/a
PE Ratio
24.23
Stock Price
27.14
Market Cap Chart
Since January 30, 2019, SHA:603351's market cap has increased from 3.41B to 3.68B, an increase of 7.86%. That is a compound annual growth rate of 1.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 3.66B | 3.88% |
| Dec 31, 2025 | 3.52B | 5.94% |
| Dec 31, 2024 | 3.33B | -6.86% |
| Dec 29, 2023 | 3.57B | 21.88% |
| Dec 30, 2022 | 2.93B | -42.75% |
| Dec 31, 2021 | 5.12B | 71.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai MicuRx Pharmaceutical | 3.92B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 3.89B |
| Qianjiang Yongan Pharmaceutical | 3.82B |
| Zhejiang Cheng Yi Pharmaceutical | 3.81B |
| PKU HealthCare Corp.,Ltd. | 3.72B |
| Huaren Pharmaceutical | 3.72B |
| Shaanxi Kanghui Pharmaceutical | 3.67B |
| Tibet AIM Pharm. | 3.66B |